RA0130

antibody from Oursmab

Targeting: CD70 CD27L, CD27LG, TNFSF7

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0130

Provider

Oursmab

Product name

Vorsetuzumab (Biosimilar Reference Antibody) (CD70)

Antibody type

Monoclonal

Description

Vorsetuzumab (PRO-131921) is an investigational humanized monoclonal antibody that targets CD70, a member of the tumor necrosis factor (TNF) superfamily. It is being developed as an antibody-drug conjugate (ADC) or naked antibody for the treatment of CD70-expressing cancers, such as renal cell carcinoma and non-Hodgkin lymphoma, aiming to directly inhibit tumor growth or deliver cytotoxic payloads.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Vorsetuzumab (Biosimilar Reference Antibody) (CD70)-RA0130-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.